Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide action in stroke therapy.

Michelle M Aarts1, Michael Tymianski

  • 1Toronto Western Hospital, Suite 4W-435, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada.

Expert Opinion on Biological Therapy
|October 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in brain frailty measures and outcomes after endovascular thrombectomy: ESCAPE-NA1 analysis.

Journal of the neurological sciences·2026
Same author

Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE-NEXT: A Multicenter, Double-Blind, Randomized Controlled Trial.

Journal of the American Heart Association·2026
Same author

Minimal Sufficient Balance Randomization and Site-Specific Treatment Allocation Imbalance in Multicenter Acute Stroke Trials.

Stroke·2026
Same author

MRI measurement of the delayed secondary ischaemic injury following endovascular thrombectomy: results from the REPERFUSE-NA1 study.

European stroke journal·2026
Same author

Nerinetide Reduces Early Infarct Growth Among Stroke Patients Undergoing EVT Without Intravenous Alteplase.

Stroke (Hoboken, N.J.)·2026
Same author

Evaluating Outcome Prediction Models in Endovascular Stroke Treatment Using Baseline, Treatment, and Posttreatment Variables.

Stroke (Hoboken, N.J.)·2026

Targeting specific protein interactions, not all glutamate receptors, offers a novel stroke therapy. This approach selectively blocks excitotoxicity without disrupting essential neuronal signaling, reducing brain damage.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Glutamate receptor antagonists show promise for stroke but fail clinically by blocking essential neurotransmission.
  • Understanding postsynaptic density and signaling cascades reveals distinct excitotoxicity pathways.

Purpose of the Study:

  • To identify and target specific molecular pathways responsible for excitotoxicity.
  • To develop a stroke therapeutic that selectively inhibits neurotoxic signals without impairing normal neuronal function.

Main Methods:

  • Dissecting intracellular signaling cascades associated with glutamate receptors.
  • Utilizing targeted, cell-permeable peptides to disrupt specific protein-protein interactions.

Main Results:

Related Experiment Videos

  • Identified distinct signaling pathways mediating excitotoxicity.
  • Demonstrated that disrupting specific protein interactions can uncouple toxic signaling from glutamate receptors.
  • Showcased the potential to attenuate neurotoxic signals selectively, reducing stroke damage.

Conclusions:

  • Targeting protein-protein interactions offers a novel therapeutic strategy for stroke.
  • This approach selectively blocks excitotoxicity, preserving essential excitatory neurotransmission and neuronal survival.
  • This method presents a practical therapeutic avenue for cerebral ischemia and stroke.